Trial
NCT04539275
VA CoronavirUs Research and Efficacy Studies-1
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
—
Condition
COVID-19
Intervention
Convalescent Plasma
Why stopped
DMC recommended early termination of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-23